SEPTInvestingStart Free

SLN SCHEDULE 13G/A: SEC filing

Invus Global Management and affiliated entities

Filed with the SEC on · accession 0002005369-26-000060

SLN filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Nov 12, 2026. A report the company filed with the SEC (the US market regulator). The stock moved +0.0% by the first close after the filing.

Summary of the filing

Invus Global Management and affiliated entities filed an amended Schedule 13G reporting beneficial ownership of approximately 4.6% of Silence Therapeutics plc's ordinary shares as of September 30, 2026, held primarily through American Depositary Shares.

For details, click here →

Key details

Ordinary shares beneficially owned by Invus Public Equities, L.P.$7.6M
Ordinary shares beneficially owned by Avicenna Life Sci Master Fund LP$1.1M
Aggregate ordinary shares beneficially owned by Raymond Debbane$8.7M
Reporting person / filerInvus Global Management, LLC
Reporting person holding 7,591,233 shares (4.1%)Invus Public Equities, L.P.
Reporting person holding 1,072,368 shares (0.6%)Avicenna Life Sci Master Fund LP
Issuer / subject companySilence Therapeutics plc
Managing member of siren and ulysRaymond Debbane

How SLN stock reacted

Close before

$19.77

Nov 11, 2026

First close after

+0.00%

$19.77

5 trading days

—

Since filing

—

✦ Ask GOAX AI about this filing — what it means for SLN, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for SLN?

Click here

Frequently asked questions

What did SLN file with the SEC on Nov 12, 2026?

SLN filed a SCHEDULE 13G/A (SEC filing). Invus Global Management and affiliated entities filed an amended Schedule 13G reporting beneficial ownership of approximately 4.6% of Silence Therapeutics plc's ordinary shares as of September 30, 2026, held primarily through American Depositary Shares.

How do I read a SCHEDULE 13G/A?

A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).

How did SLN stock react to this filing?

SLN closed at $19.77 before the filing and $19.77 on Nov 12, 2026 (+0.00%).

Other SLN SEC filings

Get alerts when SLN files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days
SLN overviewSLN analysisSLN newsLatest SEC filings